Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2014
07/30/2014CN103957925A 具有γ干扰素的抗原呈递癌症疫苗 IFN-γ has an antigen-presenting cancer vaccine
07/30/2014CN103957924A 促红细胞生成素衍生肽及其用途 Erythropoietin-derived peptides and their uses
07/30/2014CN103957923A 用于抑制包括癌干细胞在内的干细胞的增殖、发育或分化的hs.459642单基因簇产物的拮抗剂 Hs.459642 product of a single gene cluster comprising an antagonist for inhibiting the proliferation of cancer stem cells, including stem cells, development or differentiation
07/30/2014CN103957898A 聚合物蛋白微粒 Protein polymer microparticles
07/30/2014CN103957875A 用于增强指甲健康的组合物 For enhancing the health of the nail compositions
07/30/2014CN103952384A 内切型硫酸软骨素/硫酸皮肤素4-o-硫酸酯酶及其编码基因与应用 Endo-sulfated chondroitin / dermatan sulfate sulfatase 4-o- its coding gene and application
07/30/2014CN103951756A TAT与PR domain的融合蛋白及其在制备抗肿瘤药物中的应用 TAT and PR domain fusion protein and its application in the preparation of antineoplastic
07/30/2014CN103951745A Kdr肽和包括该肽的疫苗 Kdr including vaccines of the peptides and peptide
07/30/2014CN103951743A 人sfrp1变体及其应用 People sfrp1 variant and its application
07/30/2014CN103951742A 西兰苔凝集素的制备方法与应用 Preparation and application of lectin Zealand moss
07/30/2014CN103951733A 一种人肿瘤抑制蛋白变体及其应用 A human tumor suppressor protein variants and its application
07/30/2014CN103951732A 一种抗菌肽 One kind of antimicrobial peptides
07/30/2014CN103948939A 多核苷酸或多肽在制备用于间皮癌的治疗剂中的应用 Polynucleotide or polypeptide is used in the manufacture of a therapeutic agent for cancer of the mesothelium
07/30/2014CN103948938A 装载凝血酶的dna自组装纳米结构、其制备方法及应用 Load thrombin dna self-assembled nanostructures, their preparation and application
07/30/2014CN103948937A 结合配体连接的微管溶素递药缀合物 Binding ligand connecting microtubules lysin drug delivery conjugates
07/30/2014CN103948923A 一种具抗肿瘤协同增效作用的药物组合物 One kind of synergy with anti-tumor pharmaceutical composition
07/30/2014CN103948916A 一种奶牛用电解质泡腾片的制备方法 A dairy cow electrolyte effervescent preparation method
07/30/2014CN103948915A 一种能够提高稳定性和口服疗效的用于预防血栓形成和溶栓的纳豆激酶组合物 A way to improve the stability and oral efficacy for the prevention of thrombosis and thrombolysis nattokinase composition
07/30/2014CN103948914A 一种可载药的低分子量水溶性壳聚糖纳米粒子的制备方法 Method for preparing low molecular weight drugs can carry a water-soluble chitosan nanoparticles
07/30/2014CN103948913A 长效胰岛素制剂 Long-acting insulin preparations
07/30/2014CN103948912A 一种含有赤芍和粘杆菌素的畜禽用复方药物 TPG and poultry containing colistin combination drug use
07/30/2014CN103948911A 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法 One kind echinocandin antifungal release microsphere formulation and preparation method
07/30/2014CN103948910A 免疫调节多肽zl-1在制备抗肿瘤药物中的用途 Immunomodulatory peptides zl-1 in the preparation of anticancer drugs in use
07/30/2014CN103948632A 蟾饲五谷虫抗菌肽的医药用途 Toad feed grain insects medicinal use of antimicrobial peptides
07/30/2014CN103948544A 重组Exendin-4鼻腔喷雾剂及其制备方法 Nasal sprays recombinant Exendin-4 and its preparation method
07/30/2014CN103099783B 经皮给药纳米制剂及其制备方法和应用 Nano transdermal administration and its preparation method and application
07/30/2014CN103059122B 一种重组猪干扰素α1及其编码基因和表达方法 A porcine interferon α1 its coding gene and recombinant expression methods
07/30/2014CN102988193B 一种能促进细胞新生及延缓皮肤老化的医学美容多胜肽 A material which promotes cell regeneration and delay skin aging and more medical cosmetic peptides
07/30/2014CN102985101B 含有病毒去活化的生长因子且pdgf与vdgf耗尽的血小板裂解物及其制备方法 Inactivated virus-containing growth factor and platelet lysate and its preparation method and vdgf depleted pdgf
07/30/2014CN102964422B 一种利用牛毛制备抗氧化肽的方法 A method for the preparation of antioxidant peptides using Niumao
07/30/2014CN102821778B 含有tip41表达或活性抑制剂作为靶基因或trail敏化剂的用于增强trail敏感性的组合物 Tip41 expression or activity inhibitor containing a target gene or a trail as a sensitizer for enhancing the sensitivity of the composition of the trail
07/30/2014CN102816215B 抑制hiv的短小多肽及药物用途 The short peptides inhibit hiv and drug use
07/30/2014CN102731658B 一种Tat PTD-Endostatin重组蛋白及其制备方法与应用 One kind of Tat PTD-Endostatin recombinant protein and its preparation method and application
07/30/2014CN102727429B 改善稳定性的匹多莫德注射液及其制备方法 Improve the stability of pidotimod injection and its preparation method
07/30/2014CN102526706B 牙周病和牙髓疾病的治疗剂以及治疗方法 The therapeutic agent of the disease and periodontal disease, and dental pulp treatments
07/30/2014CN102525903B 一种匹多莫德的口服液体制剂 One kind of oral liquid preparations pidotimod
07/30/2014CN102488888B 一种含有棘白菌素类抗真菌剂的药用组合物及其制备方法和用途 Containing echinocandin antifungal pharmaceutical composition and its preparation method and uses
07/30/2014CN102358752B 与GLP-1和肠促胰岛素类似物(exendin)有关的发明 And GLP-1 and incretin analogues (exendin) related inventions
07/30/2014CN102307894B 螨过敏原之变体及其用途 Mite allergen variants and the use of
07/30/2014CN102292069B 囊泡制剂 Vesicle preparation
07/30/2014CN102112145B 神经内分泌病的抑制 Inhibition of neuroendocrine disease
07/30/2014CN101987865B 含有乙内酰脲结构的促黄体生成素释放激素拮抗剂 Luteinizing containing hydantoin structures generate hormone releasing hormone antagonist
07/30/2014CN101969929B 粉末状蛋白质组合物及其制备方法 Powdered protein composition and preparation method
07/30/2014CN101795704B 经口组合物 Oral composition
07/30/2014CN101790538B 胰高血糖素/glp-1受体共激动剂 Glucagon / glp-1 receptor co-agonist is
07/30/2014CN101511823B 多功能生物活性化合物 Multifunctional bioactive compounds
07/29/2014US8793074 Sequence covariance networks, methods and uses therefor
07/29/2014US8791285 Activatable nanoprobes for intracellular drug delivery
07/29/2014US8791239 Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same
07/29/2014US8791238 Artificial binding proteins based on ubiquitin
07/29/2014US8791236 Method of acylating a peptide or protein
07/29/2014US8791234 Intestinal peptide targeting ligands
07/29/2014US8791233 Maspin-based peptides and methods of use thereof
07/29/2014US8791076 Agonists of neurotrophin receptors and their use as medicaments
07/29/2014US8791075 Methods and compositions for inhibition of BCL6 repression
07/29/2014US8791074 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
07/29/2014US8791073 Peptide-modified polyurethane compositions and associated methods
07/29/2014US8791072 Modulating neuromuscular junction density changes in botulinum-toxin treated tissue
07/29/2014US8791071 Cartilage material
07/29/2014US8791070 Glycopegylated factor IX
07/29/2014US8791069 Pharmaceutical composition of nanoparticles
07/29/2014US8791068 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
07/29/2014US8791067 Method for treating malaria
07/29/2014US8791064 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds
07/29/2014US8791062 Skin permeating and cell entering (SPACE) peptides and methods of use thereof
07/29/2014US8791061 Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
07/29/2014US8791060 Composition and use of phyto-percolate for treatment of disease
07/29/2014US8790922 RNA sequence-specific mediators of RNA interference
07/29/2014US8790920 Decellularized bone marrow extracellular matrix
07/29/2014US8790897 Treatment of mucus hypersecretion
07/29/2014US8790895 Generation of artificial binding proteins on the basis of ubiquitin proteins
07/29/2014US8790883 Methods of identifying NF-κB inhibitors
07/29/2014US8790705 Spherical microcapsules comprising GLP-1 peptides, their production and use
07/29/2014US8790704 Combination peptide-nanoparticles and delivery systems incorporating same
07/29/2014US8790699 Foam-formed collagen strand
07/29/2014US8790698 Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
07/29/2014US8790691 Modified drugs for use in liposomal nanoparticles
07/29/2014US8790678 Biomaterials having nanoscale layers and coatings
07/29/2014US8790653 Peptide inhibitors for mediating stress responses
07/29/2014US8790641 Production of high mannose proteins in plant culture and therapeutic uses thereof
07/29/2014US8790640 Treating inflammation with a binding system
07/29/2014US8790639 Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
07/29/2014CA2740911C Whey protein compositions, methods and uses
07/29/2014CA2718652C Process for producing ubiquinone-10
07/29/2014CA2697205C Peptidomimetic protease inhibitors
07/29/2014CA2685270C Expression vectors for stimulating an immune response and methods of using the same
07/29/2014CA2654884C Macrocyclic compounds as antiviral agents
07/29/2014CA2653537C Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
07/29/2014CA2610281C Therapeutic agent for cancer
07/29/2014CA2568781C Intrathymic administration of viral vectors for the induction of immune tolerance, the prevention or treatment of immunodeficiencies or autoimmune diseases
07/29/2014CA2554166C Methods for reducing oxidative damage
07/29/2014CA2549386C Methods for synthesis of encoded libraries
07/29/2014CA2548896C Multimeric galectin-1 and its use for inducing il-10 production
07/29/2014CA2540539C A mixture for transdermal delivery of low and high molecular weight compounds comprising an ethoxylated oil
07/29/2014CA2494974C Il-7 drug substance, composition, preparation and uses
07/29/2014CA2463772C Thrombin-cleavable chimeric proteins
07/29/2014CA2455365C Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
07/29/2014CA2449713C Calcium phosphate delivery vehicles for osteoinductive proteins
07/29/2014CA2310097C Novel exendin agonist compounds
07/24/2014WO2014113802A1 TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 3163